Speakers

Dr Lloyd McCann is the Chief Executive Officer for Mercy Radiology and Clinics, and is the Head of Digital Health for Healthcare Holdings Limited.

He is a fellow of the Royal Australasian College of Medical Administrators. Lloyd worked as a Beachheads Advisor for New Zealand Trade and Enterprise. Whilst based in the UK, Lloyd worked as the Medical Director for Harris Corporation, Healthcare Solutions and was an elected member on the TechUK Health and Social care Board as well as a Technical Advisory Group Member for the Global e-Health Ambassadors Programme. He completed a mixed clinical and managerial fellowship at the Oxford University Hospitals NHS Trust in Emergency Medicine and Performance Improvement. 

Lloyd has worked across public and private health in New Zealand in clinical, consultancy and leadership roles. He was a member of the Expert Panel that conducted the review of the NZ Health and Disability System over 2018-2020. He is currently also a member of the ACC Health Services Strategy Advisory Board.

Lloyd is an equity advocate and an advocate for digitally enabled, value-based care.

Lisa joined PHARMAC in January 2008 as General Counsel following seven years in the UK working for a large multinational pharmaceutical company. From 2013 to 2018 Lisa led the Pharmaceutical Funding Team within the Operations Directorate. She was appointed to the Senior Leadership Team in February 2018.

As Director of Operations Lisa oversees the Pharmaceutical Funding, Devices Funding, Procurement & Contracts, Health Economics, Device Strategy & Development, and Schedule Strategy and Development teams.

Deb Bailey is a leadership coach, facilitator and speaker specializing in the areas of personal leadership impact, high performing teams, strategy and culture. .  Deb is the Director of Deb Bailey Ltd, a Practice dedicated to enhancing the quality, effectiveness and results of leaders and their teams.   Prior to starting her own Practice, Deb spent over 20 years at Fisher & Paykel Healthcare in executive and senior leadership roles with a strong focus on people and culture.  Throughout her career to date, Deb has worked with leaders and their teams around the world to identify, develop and implement effective strategies, frameworks and tools that equip leaders and teams to initiate and continue a high-performance journey.  Deb’s experience spans many industries including medical devices, facilities management, recruitment, construction, the insurance sector and more.  Deb is certified as both an mBIT Coach and Strategic Interventionist Coach and holds an MBA and PGDip in Human Resources.

Ryl Jensen has taken the new position of General Manager of NZHIT. Ryl comes with a background in IT having previously worked for the likes of IBM, EDS, and Merrill Lynch HSBC in London. She worked in Customer Relationship Management and Disaster Recovery, responsible for Service Level Agreements and Service Delivery Management. She has a strong customer focus and is passionate about health policy, research, and helping people. Ryl has been active in the Health and Disability Sector for a number of years, firstly being an advocate for women’s health and then later for digital interoperability. At a Government level she has written and contributed to health policy. She has a strong passion for the health sector, in particular digital health, and how it can be a key enabler to improve health outcomes and healthcare delivery. She is currently completing her final year of her Masters of Health at Victoria University, with a focus on health policy, planning, and systems structures. Ryl was one of three main contributors to NZHIT’s Health Opportunities Report Hauora, Mauri Ora: Enabling a Healthier Aoteroa New Zealand.

Emily is a senior policy advisor in the Transition Unit for Health Reform, with a focus on digital and data. Emily is also a Director at EY, in the Oceania Health Practice, and advises health organisations across Australia and New Zealand on digital and data strategy. Emily’s previous role at EY was global lead for Digital Health,  during which time she worked in over 20 countries, helping health systems adapt new technologies to deliver more effective and equitable healthcare services. Emily has an academic background in clinical informatics and completed a research fellowship at Stanford Medical School.

Prior to being appointed to the role of General Manager & Country Director, Medical New Zealand, Sarah relocated to Singapore in the position of APAC Senior Director for Ethicon’s largest platform, Wound Closure & Repair (WC&R). Sarah was a member of Ethicon’s Global and Regional Leadership Team. During this period, Sarah played an integral role in shaping the global WC&R strategy, accelerating market access in APAC through real world evidence, surgeon education and shaping future product and service innovation.

Sarah has held diverse senior leadership roles across Johnson & Johnson Medical and Janssen, in the disease state/specialty areas of General Surgery, Bariatrics, Orthopedics, Diabetes Management, Oncology, Immunology and Medical Affairs. Over her 14 years at J&J, Sarah and her teams have partnered closely with Health Economics and Government Affairs and Policy to accelerate market access and overcome reimbursement challenges.

Sarah is passionate about Women in Leadership in Med Tech and was a founding committee member of J&J’s ANZ Diversity and Inclusion ERG and strategy.

Sarah has a Bachelor of Business (Marketing) from University of Technology, Sydney, and a Master of Business Administration (with High Distinction) from Charles Sturt University. Sarah was also a graduate from the J&J ASCEND Global Women Senior Leadership Program in 2018.

Erin has extensive experience of more than 15 years in the MedTech industry in New Zealand, and over 10 years prior working clinically in healthcare. In the last 6 years she has been an active contributor on the Board of MTANZ and has held the Chair position for the last 3 years. Erin was a founding member of the WiHT, initiating a collaboration in 2018 across the HealthTech space and has been a Steering Group member since. She has a passion for enabling and mentoring women to progress in the industry and values the development of networks to share ideas and knowledge.

Faye Sumner is the Chief Executive Officer for the Medical Technology Association of New Zealand (MTANZ). As CEO, she has been at the forefront of negotiations with the Government in the development of proposed New Zealand medical device therapeutic regulations and the move to centralized procurement of medical devices for New Zealand.

In the 2018 Queen’s Birthday Honours, Faye was appointed Companion of the New Zealand Order of Merit (CNZM) for her services to the medical technology sector.

Faye introduced a Code of Practice for the NZ medical technology industry in 2005 with the guidelines now well accepted by industry, healthcare professionals and procurement agencies

Faye was a member of the Asia Pacific Economic Cooperation (APEC) Code of Business Ethics for Medical Devices Expert Working Group that developed the 2011 Kuala Lumpur Principles and continues today as a leader and mentor for this APEC initiative to establish ethical business practices within the APEC medical device communities. 

Faye is a Board member of the Global Medical Technology Alliance (GMTA), an international body of global associations that engages directly with the World Health Organisation (WHO). 

Faye is a Trustee of the University of Auckland, Medical & Health Sciences Foundation, and a member of the University’s MedTech Centre of Research Excellence Governing Board. Faye is a Board member of the Government’s NZ Standards Approval Board, deputy Chair of the NZ Heart Foundation and Chair of the Heart Health Trust.